Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study.
Ares-Gómez S, Mallah N, Pardo-Seco J, Malvar-Pintos A, Pérez-Martínez O, Otero-Barrós MT, Súarez-Gaiche N, Santiago-Pérez MI, González-Pérez JM, López-Pérez LR, Rosón B, Alvárez-Gil RM, Ces-Ozores OM, Nartallo-Penas V, Mirás-Carballal S, Rodríguez-Tenreiro C, Rivero-Calle I, Salas A, Durán-Parrondo C, Martinón-Torres F. Ares-Gómez S, et al. Among authors: duran parrondo c. Pediatr Allergy Immunol. 2024 May;35(5):e14131. doi: 10.1111/pai.14131. Pediatr Allergy Immunol. 2024. PMID: 38700124
Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain.
Pardo-Seco J, Mallah N, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Rodríguez-Tenreiro C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F. Pardo-Seco J, et al. Int J Environ Res Public Health. 2022 Mar 29;19(7):4039. doi: 10.3390/ijerph19074039. Int J Environ Res Public Health. 2022. PMID: 35409724 Free PMC article.
Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain.
Mallah N, Pardo-Seco J, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Nartallo-Penas V, Mirás-Carballal S, Rodríguez-Tenreiro C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F. Mallah N, et al. Environ Res. 2022 Dec;215(Pt 2):114252. doi: 10.1016/j.envres.2022.114252. Epub 2022 Sep 10. Environ Res. 2022. PMID: 36096168 Free PMC article.
Improving Influenza Vaccine Acceptance in Children Leveraging on COVID-19 Vaccination Lessons.
Ares-Gomez S, Mallah N, Pardo-Seco J, Nartallo-Penas V, Mirás-Carballal S, Rodriguez-Tenreiro-Sánchez C, Rivero-Calle I, Piñeiro-Sotelo M, Durán-Parrondo C, Martinón-Torres F. Ares-Gomez S, et al. Among authors: duran parrondo c. Arch Bronconeumol. 2023 Aug;59(8):531-533. doi: 10.1016/j.arbres.2023.03.011. Epub 2023 Mar 21. Arch Bronconeumol. 2023. PMID: 37003883 Free PMC article. No abstract available.
COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain.
Mallah N, Pardo-Seco J, Ares-Gómez S, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Nartallo-Penas V, Mirás-Carballal S, Rodríguez-Tenreiro-Sánchez C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F. Mallah N, et al. Among authors: duran parrondo c. Pediatr Allergy Immunol. 2023 Oct;34(10):e14037. doi: 10.1111/pai.14037. Pediatr Allergy Immunol. 2023. PMID: 37877845
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.
Ares-Gómez S, Mallah N, Santiago-Pérez MI, Pardo-Seco J, Pérez-Martínez O, Otero-Barrós MT, Suárez-Gaiche N, Kramer R, Jin J, Platero-Alonso L, Alvárez-Gil RM, Ces-Ozores OM, Nartallo-Penas V, Mirás-Carballal S, Piñeiro-Sotelo M, Malvar-Pintos A, González-Pérez JM, Rodríguez-Tenreiro-Sánchez C, Rivero-Calle I, Salas A, Durán-Parrondo C, Martinón-Torres F; NIRSE-GAL study group. Ares-Gómez S, et al. Among authors: duran parrondo c. Lancet Infect Dis. 2024 Aug;24(8):817-828. doi: 10.1016/S1473-3099(24)00215-9. Epub 2024 Apr 30. Lancet Infect Dis. 2024. PMID: 38701823
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol.
Mallah N, Ares-Gómez S, Pardo-Seco J, Malvar-Pintos A, Santiago-Pérez MI, Pérez-Martínez O, Otero-Barrós MT, Suárez-Gaiche N, Kramer R, Jin J, Platero-Alonso L, Alvárez-Gil RM, Ces-Ozores OM, Nartallo-Penas V, Mirás-Carballal S, Piñeiro-Sotelo M, González-Pérez JM, Rodríguez-Tenreiro C, Rivero-Calle I, Salas A, Durán-Parrondo C, Martinón-Torres F. Mallah N, et al. Among authors: duran parrondo c. Hum Vaccin Immunother. 2024 Dec 31;20(1):2348135. doi: 10.1080/21645515.2024.2348135. Epub 2024 May 13. Hum Vaccin Immunother. 2024. PMID: 38738683 Free PMC article.
Systematic influenza vaccination in the pediatric population.
Otero-Barrós MT, Durán-Parrondo C. Otero-Barrós MT, et al. An Pediatr (Engl Ed). 2023 Jan;98(1):1-2. doi: 10.1016/j.anpede.2022.11.003. Epub 2022 Nov 29. An Pediatr (Engl Ed). 2023. PMID: 36460607 Free article. No abstract available.
21 results